Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03715335 · ClinicalTrials.gov registry record · NA
Adolescent Sexually Transmitted Infection Screening in the Emergency Department
A NA study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 98,413
- Enrollment target
NCT03715335: Completed NA study, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT03715335 is a NA study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 98,413 participants, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (6919% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03715335, a NA study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 98,413 participants
- Enrollment target
Study Summary
Sexually transmitted infections (STIs) are highly prevalent among adolescents. Clinical practices related to screening, diagnosis, treatment, and prevention of STIs among adolescents are suboptimal. There is a need to expand our screening programs to nontraditional healthcare settings such as emergency departments (ED) and to determine the most efficient and cost-effective method for providing this screening. The goal of this study is to leverage our recent insights obtained from single center ED-based adolescent GC/CT screening research and apply them across a national pediatric ED research network to determine the most clinically effective and cost-effective screening approach for adolescents when implemented into a real-world clinical setting through a pragmatic trial. This will be accomplished through a network of children's hospital EDs with a track record of robust research collaboration (Pediatric Emergency Care Applied Research Network or PECARN). This intervention will rely on an innovative approach that electronically integrates patient-reported data to guide clinical decision support. The investigators will apply human factors modeling methods to perform ED workflow evaluations at each participating pediatric ED to determine the most efficient way to integrate the screening process into clinical care. The investigators will then conduct a comparative effectiveness pragmatic trial of targeted STI screening versus universally offered STI screening through electronic integration of patient reported data for provision of clinical decision support. The investigators will develop decision analytic models to evaluate the cost-effectiveness of targeted screening compared to universally offered screening.
Primary Outcome
Our primary outcome measure is GC/CT detection rates per 1000 eligible patients.
Interventions
- OTHER Targeted STI Screening
- OTHER Universally Offered STI Screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98,413 participants |
| Start Date | 2020-07-20 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
What the finished NCT03715335 record still lists
NCT03715335 is an interventional study that assigns participants to a tested intervention. Its 98,413 participants enrollment target places it among the larger protocols in the corpus, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (6919% higher).
The record links to 0 conditions, and to 2 interventions - of which Targeted STI Screening is the first listed.
NCT03715335 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03715335 about?
NCT03715335 is a clinical study titled "Adolescent Sexually Transmitted Infection Screening in the Emergency Department". Sexually transmitted infections (STIs) are highly prevalent among adolescents. Clinical practices related to screening, diagnosis, treatment, and prevention of STIs among adolescents are suboptimal. There is a need to expand our screening programs to nontraditional healthcare settings such as emerge...
What is the current status of trial NCT03715335?
This trial is currently completed. It is a NA study. The enrollment target is 98,413 participants. The study started on 2020-07-20. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT03715335?
The interventions under investigation include: Targeted STI Screening (OTHER), Universally Offered STI Screening (OTHER).
Who is sponsoring clinical trial NCT03715335?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03715335's enrollment target sits among peer trials
98,413 3rd of 2000 higher than 1,998 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01351545 · 99,999 participants
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- NCT02620852 · 100,000 participants · NA
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- NCT03277365 · 100,000 participants · NA
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
- NCT04281823 · 100,000 participants
DeBakey Cardiovascular Magnetic Resonance Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI